Indu Subramanian
A5005587948- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Autism Spectrum Disorder Research
- Transcranial Magnetic Stimulation Studies
- Olfactory and Sensory Function Studies
- Occupational Therapy Practice and Research
- Long-Term Effects of COVID-19
- Cerebral Palsy and Movement Disorders
- Botulinum Toxin and Related Neurological Disorders
- Nuclear Receptors and Signaling
- Restless Legs Syndrome Research
- Dysphagia Assessment and Management
- Palliative Care and End-of-Life Issues
- Biochemical Analysis and Sensing Techniques
- Health disparities and outcomes
- Dementia and Cognitive Impairment Research
- Stroke Rehabilitation and Recovery
- Family Support in Illness
- Balance, Gait, and Falls Prevention
- Effects and risks of endocrine disrupting chemicals
- LGBTQ Health, Identity, and Policy
- Telemedicine and Telehealth Implementation
- Behavioral and Psychological Studies
- Neurological diseases and metabolism
- Spaceflight effects on biology
University of California, Los Angeles
2002-2025
West Los Angeles College
2012-2025
VA Greater Los Angeles Healthcare System
2020-2024
Parkinson's UK
2024
University of Washington
2020-2023
Bastyr University
2023
University of North Texas
2023
UCLA Medical Center
2023
Harborview Medical Center
2020
University of Rochester Medical Center
2020
<h3>Objectives:</h3> Our objective was to compare long-term outcomes of deep brain stimulation (DBS) the globus pallidus interna (GPi) and subthalamic nucleus (STN) for patients with Parkinson disease (PD) in a multicenter randomized controlled trial. <h3>Methods:</h3> Patients randomly assigned GPi (n = 89) or STN DBS 70) were followed 36 months. The primary outcome motor function on stimulation/off medication using Unified Parkinson9s Disease Rating Scale subscale. Secondary included...
Abstract To test the association between impaired olfaction and other prodromal features of PD in Parkinson At‐Risk Syndrome Study. The onset olfactory dysfunction typically precedes motor features, suggesting that testing could be used as a screening test. A combined strategy uses nonmotor along with testing, may more efficient than hyposmia alone for detecting risk PD. Individuals no neurological diagnosis completed mail survey, including 40‐item University Pennsylvania Smell...
Social isolation and its deleterious effects on health increases with age in the general population. People Parkinson's Disease (PWP) are no exception. is a risk factor for worsened outcomes increased mortality. Symptoms such as depression sleep dysfunction adversely affected by loneliness. There paucity of research social disease (PD), which all more critical now setting distancing due to COVID-19. The goal this study was survey individuals PD evaluate whether associated symptom severity...
Abstract Personalized medicine considering sex, gender, and cultural context has become the vanguard of delivery care. However, women's issues in Parkinson disease (PD), especially from a psychosocial standpoint, have been an overlooked field. The key research areas include women‐inclusive drug device studies genetic hormonal considerations. Moreover, women with PD need to be educated empowered on how communicate their symptoms needs, get engaged research, organized as community, support one...
Importance Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies more than 3 years follow-up are lacking. Objective To investigate long-term effects STN-DBS on QOL compared standard-of-care medication (MED). Design, Setting, and Participants In this prospective, observational, quasi-experimental, longitudinal nonrandomized trial, 183 were screened for eligibility 167 enrolled from...
Abstract The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors STN-DBS this study. In prospective, open-label, multicentre study, we assessed patients with undergoing for PD preoperatively and at 6-month follow-up postoperatively. the Hospital Anxiety Depression Scale (HADS-anxiety depression subscales), Unified Rating Scale-motor examination, Scales Outcomes PD-motor (SCOPA-M)-activities...
Abstract To identify predictors of 36-month follow-up quality life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). In this ongoing, prospective, multicenter international study (Cologne, Manchester, London) including 73 patients undergoing STN-DBS, we assessed the following scales preoperatively and at 6-month follow-up: PD Questionnaire-8 (PDQ-8), NMSScale (NMSS), Scales for Outcomes (SCOPA)-motor examination, -activities daily...
Object. Several investigators have described the motor benefits derived from performing unilateral stereotactic pallidotomy for treatment of Parkinson disease (PD), but little is known about efficacy and complication rates bilateral procedures. The goal this study was to assess both these factors in 12 patients. Methods. Eleven patients with medically intractable PD underwent staged one patient a simultaneous procedure. Unilateral resulted an improvement patients' Unified Disease Rating...
In 2024 the US environment agency banned most uses of a solvent that has been widely used for century. <b>Indira Subramanian</b> explains why, and why ban might not be enough to halt rising cases Parkinson's disease